On Monday, the White House stated that it had identified a connection between the use of paracetamol in pregnancy – marketed in the US as Tylenol – and autism in children. He had teed up the news over the weekend, saying “I think we found an answer to autism”. “There is no new evidence that would require changes to the current EU recommendations for use,” an agency spokesperson told Euronews. In 2019, the Agency reviewed studies on the neurodevelopment of children exposed to paracetamol during pregnancy and concluded that the findings were inconclusive, with no evidence of a link to neurodevelopmental disorders. As with all medicines, the EMA and national competent authorities in the EU carry out continuous safety monitoring of products containing paracetamol.